Hermetica Superfood Encyclopedia
The Short Answer
Astragaloside IV is a triterpene saponin extracted from Astragalus membranaceus root that demonstrates anti-inflammatory and antioxidant properties. It works primarily by inhibiting NF-κB signaling pathways and activating Nrf2-mediated antioxidant responses.
CategoryNamed Bioactive Compounds
GroupCompound
Evidence LevelStrong
Primary Keywordastragaloside IV benefits
Synergy Pairings3
Astragaloside IV — botanical close-up
Health Benefits
Origin & History
Natural habitat
Astragaloside IV (AS-IV) is a pentacyclic triterpenoid saponin isolated from the dried root of Astragalus membranaceus, a traditional Chinese medicinal herb. It is extracted using n-butanol followed by HPLC purification, with the Chinese Pharmacopoeia requiring a minimum content of 0.080% AS-IV in quality Astragali Radix preparations.
“Astragaloside IV is the primary active constituent in Astragalus membranaceus, used in Traditional Chinese Medicine for centuries to tonify qi and treat fatigue, immune deficiency, and cardiovascular issues. Modern pharmacological research on its anti-tumor, anti-inflammatory, and antioxidant properties aligns with these traditional applications.”Traditional Medicine
Scientific Research
The research dossier reveals a critical gap: no human clinical trials, RCTs, or meta-analyses for Astragaloside IV were identified. All available evidence comes from preclinical studies using in vitro and animal models, with researchers calling for human trials to validate observed anticancer, anti-inflammatory, and cardioprotective effects.
Preparation & Dosage
Traditional preparation
No clinically studied dosage ranges for humans have been established. Preclinical studies use concentrations of 50-100 ng/mL in cell culture models, but these cannot be extrapolated to human dosing. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Astragaloside IV is a purified triterpenoid saponin compound (cycloartane-type), not a whole food ingredient, therefore it contains no meaningful macronutrients, dietary fiber, vitamins, or minerals in its isolated form. Molecular weight: 784.98 g/mol (C41H68O14). It is the primary bioactive glycoside extracted from Astragalus membranaceus root, typically present at 0.01–0.04% by dry weight in raw root material. As an isolated compound, it is administered in concentrations ranging from 25–100 mg/kg in preclinical animal models and at 50–100 ng/mL in cell culture studies. Bioavailability is notably poor when taken orally: absolute oral bioavailability is estimated at approximately 2.2–3.8% in rodent models due to low intestinal permeability and extensive first-pass metabolism, with a Tmax of approximately 0.5–1 hour and half-life of roughly 2–4 hours. Gut microbiota partially hydrolyze the glycoside moieties, producing aglycone metabolites (cycloastragenol) which may exhibit enhanced membrane permeability. Lipophilicity is low-to-moderate (logP approximately 0.3), limiting passive diffusion. Nanoparticle and phospholipid complex formulations have been shown in preclinical studies to increase bioavailability by 3–5 fold. No caloric, protein, fat, or carbohydrate content is nutritionally relevant in supplemental doses (typically 5–50 mg per dose in commercial preparations).
How It Works
Mechanism of Action
Astragaloside IV suppresses inflammatory responses by blocking NF-κB nuclear translocation and inhibiting the TLR4/MyD88 signaling cascade. It enhances cellular antioxidant defenses through Nrf2 pathway activation, increasing expression of antioxidant enzymes like HO-1 and NQO1. The compound also modulates cell cycle proteins and promotes apoptosis in abnormal cells through p53 and caspase pathway activation.
Clinical Evidence
Current evidence for astragaloside IV is primarily limited to preclinical studies and in vitro research. Animal studies have shown anti-inflammatory effects at doses of 10-50 mg/kg, with significant reductions in inflammatory markers like TNF-α and IL-6. Antioxidant activity has been demonstrated in cell culture studies using concentrations of 1-100 μM. No human clinical trials have been published to date, making clinical efficacy and optimal dosing unclear.
Safety & Interactions
Safety data for astragaloside IV in humans is limited due to lack of clinical trials. Animal studies suggest good tolerability at therapeutic doses, though higher concentrations may cause gastrointestinal upset. No specific drug interactions have been documented, but theoretical interactions may exist with immunosuppressive medications due to immune-modulating effects. Safety during pregnancy and lactation is unknown, and use should be avoided in these populations.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
AS-IV3-O-β-D-xylopyranosyl-6-O-β-D-glucopyranosyl-cycloastragenolCycloastragenol 3-O-β-D-xylopyranosyl-6-O-β-D-glucopyranosideAstragaloside A4Huangqi Saponin IVAST-IV
Frequently Asked Questions
Does astragaloside IV actually work in humans or only in lab studies?
Currently, all evidence for astragaloside IV comes from preclinical research — in vitro cell culture models and animal studies. No human clinical trials, randomised controlled trials, or meta-analyses have been completed. While mechanisms such as NF-κB inhibition and Nrf2 activation are well-characterised in laboratory settings, researchers explicitly acknowledge the gap between these findings and proven human efficacy. Until clinical trials are conducted, any benefits observed in cell or animal models cannot be reliably extrapolated to human outcomes.
How does astragaloside IV differ from regular astragalus root extract?
Astragalus membranaceus root contains hundreds of bioactive compounds including polysaccharides, flavonoids, and multiple saponins. Astragaloside IV is one specific isolated triterpene saponin from that root, studied for its distinct mechanisms: NF-κB signalling inhibition, TLR4/MyD88 pathway suppression, and Nrf2-mediated antioxidant activation. Standard astragalus extracts deliver a broad spectrum of these compounds at lower individual concentrations, whereas astragaloside IV supplements target a single purified compound, allowing for more mechanism-specific investigation, though human clinical validation is still lacking for both.
Can astragaloside IV support heart health?
Preclinical animal studies suggest cardioprotective potential for astragaloside IV, attributed to modulation of multiple signalling pathways that reduce oxidative stress and inflammation in cardiac tissue. These effects are thought to involve Nrf2-driven antioxidant enzyme upregulation and suppression of inflammatory cascades that can damage heart cells. However, no human clinical trials have confirmed these effects in people with heart conditions. It should not be used as a substitute for evidence-based cardiovascular treatments, and a healthcare provider should always be consulted.
Does astragaloside IV boost the immune system?
Astragaloside IV is associated with immune support through its parent herb Astragalus membranaceus, which has a long history in Traditional Chinese Medicine as a qi tonic. Mechanistically, its suppression of TLR4/MyD88 signalling and modulation of inflammatory cytokines may influence immune regulation. However, the immune-boosting claims currently lack clinical validation from human trials. Traditional use provides historical context, but preclinical findings alone are insufficient to confirm meaningful immune enhancement in healthy or immunocompromised individuals.
What antioxidant mechanisms does astragaloside IV use?
Astragaloside IV activates the Nrf2 transcription factor pathway, a master regulator of cellular antioxidant defence. Upon activation, Nrf2 upregulates expression of cytoprotective enzymes including haem oxygenase-1 (HO-1) and NAD(P)H quinone oxidoreductase 1 (NQO1), which neutralise reactive oxygen species and reduce oxidative damage. Additionally, astragaloside IV demonstrates direct reactive oxygen species scavenging activity in in vitro studies. These mechanisms are well-characterised at the cellular level but have not yet been confirmed through human clinical research.
Can I take astragaloside IV with other supplements or medications?
No clinical data exists on astragaloside IV drug or supplement interactions in humans. Given that it modulates immune-related pathways like TLR4/MyD88 and influences antioxidant enzyme expression via Nrf2, theoretical interactions with immunosuppressant medications or drugs metabolised through affected pathways are plausible concerns. Anyone taking prescription medications — particularly immunosuppressants, corticosteroids, or cardiovascular drugs — should consult a qualified healthcare provider before combining astragaloside IV with their existing regimen, as the absence of clinical trial data makes interaction risk unpredictable.
Is astragaloside IV the same as cycloastragenol?
No, astragaloside IV and cycloastragenol are related but distinct compounds. Both are triterpene saponins derived from Astragalus membranaceus, and cycloastragenol is actually a hydrolysis product of astragaloside IV — meaning it can be produced when astragaloside IV is broken down. Cycloastragenol has been more specifically studied for telomerase activation and potential anti-ageing effects. Astragaloside IV research focuses more on NF-κB inhibition, antioxidant activity via Nrf2, and anti-inflammatory properties. The two compounds have overlapping origins but different mechanistic profiles and research trajectories.
What are the known side effects of astragaloside IV?
No systematic human safety data or adverse event profiles have been established for astragaloside IV, as no human clinical trials have been conducted. Its parent herb, Astragalus membranaceus, has a long history of traditional use and is generally considered well-tolerated, but isolated concentrated saponins may behave differently from whole-herb preparations. Potential theoretical concerns include immune modulation in sensitive individuals. Without clinical trial safety data, the full side effect profile remains unknown. Individuals who are pregnant, immunocompromised, or on medications should seek medical advice before use.
What is the recommended dosage of astragaloside IV for humans?
No clinically established human dosage exists for astragaloside IV. All dosing data comes from preclinical research — cell culture studies typically use concentrations of 50–100 ng/mL, which cannot be reliably extrapolated to human supplementation. Supplement manufacturers often set arbitrary doses without clinical backing. Until human trials establish safe and effective dosing ranges, anyone considering astragaloside IV should consult a qualified healthcare provider before use.
Is astragaloside IV safe to take long-term?
Long-term safety data for astragaloside IV in humans is essentially nonexistent. No human clinical trials have evaluated its safety profile, tolerability, or adverse event frequency over extended periods. While the parent plant Astragalus membranaceus has a long history of traditional use, the isolated compound astragaloside IV behaves differently. Without robust safety data, long-term use carries unknown risks. Healthcare provider guidance is strongly recommended before sustained supplementation.
Can astragaloside IV help with inflammation?
Astragaloside IV shows anti-inflammatory activity in preclinical models by blocking NF-κB nuclear translocation and suppressing the TLR4/MyD88 signaling cascade, both key drivers of inflammatory responses. These findings come exclusively from in vitro and animal studies. While the mechanistic rationale is scientifically plausible, no human clinical trials have confirmed these effects in people. Its real-world anti-inflammatory benefit in humans remains unvalidated and should not be assumed from preclinical data alone.
Does astragaloside IV have anticancer properties?
In cell culture models, astragaloside IV at concentrations of 50–100 ng/mL has demonstrated potential anticancer activity by modulating cell cycle proteins, activating p53 pathways, and promoting apoptosis via caspase cascades in abnormal cells. However, all evidence is limited to laboratory studies. No human trials exist to confirm anticancer efficacy or safety. These findings are considered hypothesis-generating only, and astragaloside IV should never be used as a cancer treatment or substitute for conventional oncology care.
Conditions This May Help
Based on the mechanism and research, Astragaloside IV may support the following health areas. Each link goes to an evidence-ranked guide of the best ingredients for that concern.
Inflammation & Joint Health
Top anti-inflammatories: turmeric, boswellia, omega-3, ginger. Evidence on NF-κB modulation and joint support.
Browse evidence-ranked ingredients →
Cognitive Function & Focus
Top nootropics: lion's mane, bacopa, ginkgo, phosphatidylserine. PubMed-cited evidence on cognitive enhancemen…
Browse evidence-ranked ingredients →
Immune System Support
Top immune boosters: reishi, chaga, elderberry, vitamin C, zinc. Clinical evidence on immune modulation.
Browse evidence-ranked ingredients →
Antioxidant Protection
Top antioxidants: astaxanthin, glutathione, vitamin E, resveratrol. Evidence on oxidative stress protection.
Browse evidence-ranked ingredients →
Or jump to the curated Best Inflammation & Joint Health Stack → top 12 evidence-ranked ingredients.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w astragaloside-iv curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
